Autologous MSC from bone marrow (University Hospital, Toulouse)

N/A

Report date: 2023/01/12 15:29:57

Base Information

Drug NameAutologous MSC from bone marrow (University Hospital, Toulouse)

Drug Alias NameN/A

ClassificationCell and gene therapy > Cell therapy > Donor > AutologousCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapyCell and gene therapy > Cell therapy > Source of cells > Bone Marrow-derived

Mechanisms of ActionStem cell replacements

TargetsNot applicable

Therapy Area/IndicationsMyocardial Ischemia

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryFrance

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesToulouse University Hospital

China Registration ClassN/A

Develop Information

Active CompaniesToulouse University Hospital

Inactive CompaniesN/A

Active IndicationsMyocardial Ischemia

Inactive IndicationsN/A

Other Information

ATC CodeN/A